Navigation Links
Johns Hopkins Medicine expands reach in Latin America
Date:2/11/2013

World-class standards for clinical outcomes and patient safety are at the core of a landmark affiliation agreement signed today between Johns Hopkins Medicine International (JHI) and Pacfico S.A. Entidad Prestadora de Salud (Pacfico Salud), a Lima, Peru-based subsidiary of Credicorp Ltd. (NYSE: BAP).

The collaboration focuses on a network of Peruvian hospitals, an oncology clinic, clinical and pathology laboratories, and outpatient centers that have recently been acquired by Pacfico Salud.

"This important endeavor is designed to raise the quality of health care services across a vast and committed corps of caregivers," says Steven J. Thompson, chief executive officer of Johns Hopkins Medicine International. "We believe that it will have significant long-term impact on Peruvian health care and are pleased to have the opportunity to collaborate with our colleagues at Pacfico Salud, and to share our innovations and best practices with health care providers in this dynamic country and beyond."

Under the terms of the agreement, which was signed in Baltimore, USA, the two organizations will focus on health system strengthening through patient safety and operational and service efficiencies. Johns Hopkins experts will work together with their Peruvian colleagues in the development of clinical and patient services programs, infection control initiatives, and quality improvement processes. The affiliation will also focus on elevating nursing and introducing innovative care concepts.

The new collaboration also aims to create an enhanced infrastructure for the delivery of patient care. At the same time, it provides a viable platform from which to launch a number of public health-focused programs related to the prevention and early detection of non-communicable diseases.

Accreditation of the network hospitals, outpatient and laboratories will be another primary goal. Currently, there are no Joint Commission International-accredited hospitals in a nation with more than 30 million citizens.

"We are very proud to have signed this agreement. It represents a turning point in the history of Peruvian health care, allowing us to be one of the driving forces of its improvement," says Guillermo Garrido Lecca, general manager of Pacfico Salud. "Through our continued collaboration and knowledge transfer initiatives with a world leader in academic medicine, we aim to become the model for local and international health care institutions."

The affiliation agreement with Johns Hopkins Medicine International is the first of its kind in Peru, one of Latin America's fastest growing economies. It also represents a major step forward for Pacfico Salud as it advances its leadership role in the Peruvian private health care realm.

The two organizations began their collaboration in 2012 with a series of activities that included an assessment of Pacfico Salud's health care facilities and an intensive training program for its leaders in health care finance and management. Pacfico Salud currently operates five inpatient facilities across the country.


'/>"/>

Contact: Natalia Bolotina
nboloti1@jhmi.edu
928-266-6318
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. 29 Johns Hopkins stem cell researchers awarded funding
2. Johns Hopkins African bioethics program receives 5-year continuation grant from NIH
3. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
4. Johns Hopkins researchers return blood cells to stem cell state
5. Johns Hopkins team finds ICU misdiagnoses may account for as many annual deaths as breast cancer
6. Johns Hopkins Armstrong Institute receives $8.9 million patient safety grant
7. Results from study of Mead Johnsons Enfamil® Human Milk Fortifier Acidified Liquid published in Pediatrics
8. Johns Hopkins scientists pair blood test and gene sequencing to detect cancer
9. The US Drug Watchdog Now Urges Women Who Suffered A Heart Attack Or Stroke After Using Yaz Yasmin Birth Control Pills To Contact The Johnson Law Group Immediately
10. The US Drug Watchdog Now Urges Any Woman Who Used The Birth Control Pills Yaz Or Yasmin And Then Had A Heart Attack Or Stroke To Call The Johnson Law Group----ASAP
11. In US first, Johns Hopkins surgeons implant brain pacemaker for Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... franchises from across the country gathered at the La Valencia Hotel in San ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with ...
(Date:2/5/2016)... ... 05, 2016 , ... Pivot Point Consulting, a leading national ... & Services for HIT Implementation Support & Staffing report with an outstanding score ... by healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Colorize ... from on one drop zone to the next using Colorize's dynamic moving camera. Colorize ... project. This package includes a 3D slideshow environment with 1 to 5 focus points ...
(Date:2/5/2016)... ... 05, 2016 , ... Calls Blacklist has just been updated by mobile app ... the developer has fixed known bugs within the app. Calls Blacklist allows its users ... not consuming any of their device’s battery power or memory. It provides a powerful ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Global Immunology Market to 2022 - Large ... growth Summary Immune-mediated inflammatory diseases are ... affect 5–7% of western populations. Although they are ... key patient demographics, they are pathophysiologically linked, being ... inappropriate immune response. Generally, disease-modifying anti-rheumatic drugs, a ...
(Date:2/4/2016)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... treat life-threatening diseases, today announced results for the ... 2015. --> --> ... our last quarterly call, we strategically advanced pre-clinical ... to establish the Aethlon Hemopurifier® as a leading ...
Breaking Medicine Technology: